These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 5380625)

  • 41. The correlation between the decline of the positive inotropic effect and the loss of cardiac glycosides from isolated atria during wash-out.
    Lüllmann H; Weber R; van Zwieten PA
    Eur J Pharmacol; 1969; 6(3):235-40. PubMed ID: 5799185
    [No Abstract]   [Full Text] [Related]  

  • 42. [Studies on the active or passive enteral resorption of cardiac glycosides].
    Mentz P; Witzleben H; Förster W
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):126-40. PubMed ID: 4674599
    [No Abstract]   [Full Text] [Related]  

  • 43. The kinetic behaviour of cardiac glycosides in vivo, measured by isotope techniques.
    Lüllmann H; van Zwieten PA
    J Pharm Pharmacol; 1969 Jan; 21(1):1-8. PubMed ID: 4388183
    [No Abstract]   [Full Text] [Related]  

  • 44. [Blood level kinetics and renal clearance of H3 peruvosid].
    Kramer P; Willms B; Horenkamp J; Scheler F
    Klin Wochenschr; 1969 Nov; 47(21):1157-66. PubMed ID: 5382005
    [No Abstract]   [Full Text] [Related]  

  • 45. [Pharmacokinetics of cardiac glycosides and clinical consequences].
    Rietbrock N; Kuhlmann J; Vöhringer HF
    Fortschr Med; 1977 Apr; 95(14):909-15, 951-4. PubMed ID: 856698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [On the distribution and metabolism of 3H-peruvoside in the guinea pig].
    Schaum E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):194. PubMed ID: 4239224
    [No Abstract]   [Full Text] [Related]  

  • 47. [Cumulative effect of cardiac glycosides. (Review)].
    Angarskaia MA; Liubartseva LA; Sokolova VE
    Farmakol Toksikol; 1969; 32(6):745-6. PubMed ID: 4909670
    [No Abstract]   [Full Text] [Related]  

  • 48. [Comparative studies in the guinea pig on serum radioactivity, excretion and tissue distribution of 3H-digitoxin and 3H-digitoxigenin].
    Gadke J; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):234-5. PubMed ID: 4242386
    [No Abstract]   [Full Text] [Related]  

  • 49. [Plasmatic levels and urinary elimination of K-strophanthoside after intravenous administration in normal humans].
    Marzo A; Ghirardi P; Riva D; Zaini G; Matteoli E; Marchetti G
    Boll Soc Ital Biol Sper; 1973 Jul; 49(11):633-6. PubMed ID: 4790664
    [No Abstract]   [Full Text] [Related]  

  • 50. [Gitoformate and digitoxin as alternatives to kidney-dependent glycosides in the therapy of cardiac insufficiency].
    Rietbrock N; Woodcock BG; Hrazdil U
    Arzneimittelforschung; 1984; 34(8):915-7. PubMed ID: 6541927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The distribution of 3H-labelled cardenolides between isolated guinea-pig atrial tissue and circulating, oxygenated whole blood.
    Lüllmann H; Peters T; van Zwieten PA
    Br J Pharmacol; 1969 Jun; 36(2):276-85. PubMed ID: 5787668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic uptake of cardiac glycosides in newborn rats, rabbits and dogs.
    Klaassen CD
    Biochem Pharmacol; 1975 Apr; 24(8):923-5. PubMed ID: 1125093
    [No Abstract]   [Full Text] [Related]  

  • 53. [On the pharmacokinetics of peruvoside. I. Comparative clinical and experimental animal studies].
    Hundeshagen H; Zeidler U; Fabel H; Garbe A; Nowak H
    Arzneimittelforschung; 1968 Dec; 18(12):1592-6. PubMed ID: 5756259
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacokinetics, bioavailability and serum levels of cardiac glycosides.
    Smith TW
    J Am Coll Cardiol; 1985 May; 5(5 Suppl A):43A-50A. PubMed ID: 3921586
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [On the determination of cardiotoxicity of cardiac glycosides in cats. 1. General bases and biophysical model for intravenous and intraduodenal infusion experiments].
    Lenke D; Schneider B
    Arzneimittelforschung; 1969 May; 19(5):687-93. PubMed ID: 5819774
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of probenecid on the in vitro absorption of cardiac glycosides.
    Damm KH; Woermann C
    Eur J Pharmacol; 1974 Sep; 28(1):157-63. PubMed ID: 4430319
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapeutic equivalence and inequivalence of chemically identical substances using cardiac glycosides for an example (author's transpl)].
    Rietbrock N
    Arzneimittelforschung; 1976; 26(1A):135-46. PubMed ID: 947193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative study of the resorption, distribution, and excretion of digitalis glycosides in experimental animals].
    Buchtela K; Drexler K; Fehringer A; Hackl H; Königstein M; Schläger J
    Wien Z Inn Med; 1970; 51(5):227-35. PubMed ID: 5535605
    [No Abstract]   [Full Text] [Related]  

  • 59. [Plasma elimination, hepatic uptake and biliary excretion of tritiated cardiac glycosides by the isolated perfused liver].
    Kolenda KD; Peters T; Seiler KU
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):375-6. PubMed ID: 4253810
    [No Abstract]   [Full Text] [Related]  

  • 60. [Metabolism of helveticoside and helveticosol derivatives].
    Kaiser F; Schaumann W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(1):87-96. PubMed ID: 4237044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.